EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS197-11045 
Organism
Homo sapiens 
Tissue/cell
ZR75-30 
Coordinate
chr2:738400-741640 
TF binding sites/motifs
Number: 31             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF14MA0740.1chr2:740080-740094GAGGGGGCGTGGCC-7.52
KLF14MA0740.1chr2:740332-740346GAGGGGGCGTGGCC-7.52
KLF14MA0740.1chr2:740647-740661GAGGGGGCGTGGCC-7.52
KLF14MA0740.1chr2:740773-740787GAGGGGGCGTGGCC-7.52
KLF16MA0741.1chr2:740397-740408GGGGGCGGGGC-6.02
KLF16MA0741.1chr2:740838-740849GGGGGCGGGGC-6.02
KLF16MA0741.1chr2:740082-740093GGGGGCGTGGC-6.62
KLF16MA0741.1chr2:740334-740345GGGGGCGTGGC-6.62
KLF16MA0741.1chr2:740649-740660GGGGGCGTGGC-6.62
KLF16MA0741.1chr2:740775-740786GGGGGCGTGGC-6.62
KLF5MA0599.1chr2:740398-740408GGGGCGGGGC-6.02
KLF5MA0599.1chr2:740839-740849GGGGCGGGGC-6.02
SP1MA0079.4chr2:740081-740096AGGGGGCGTGGCCCA-6.12
SP1MA0079.4chr2:740333-740348AGGGGGCGTGGCCCA-6.12
SP1MA0079.4chr2:740648-740663AGGGGGCGTGGCCCA-6.12
SP1MA0079.4chr2:740774-740789AGGGGGCGTGGCCCA-6.12
SP3MA0746.2chr2:740081-740094AGGGGGCGTGGCC-6.82
SP3MA0746.2chr2:740333-740346AGGGGGCGTGGCC-6.82
SP3MA0746.2chr2:740648-740661AGGGGGCGTGGCC-6.82
SP3MA0746.2chr2:740774-740787AGGGGGCGTGGCC-6.82
SP4MA0685.1chr2:740394-740411GGAGGGGGCGGGGCCCA-6.05
SP4MA0685.1chr2:740079-740096CGAGGGGGCGTGGCCCA-6.17
SP4MA0685.1chr2:740331-740348CGAGGGGGCGTGGCCCA-6.17
SP4MA0685.1chr2:740646-740663CGAGGGGGCGTGGCCCA-6.17
SP4MA0685.1chr2:740772-740789CGAGGGGGCGTGGCCCA-6.17
SP8MA0747.1chr2:740081-740093AGGGGGCGTGGC-6.92
SP8MA0747.1chr2:740333-740345AGGGGGCGTGGC-6.92
SP8MA0747.1chr2:740648-740660AGGGGGCGTGGC-6.92
SP8MA0747.1chr2:740774-740786AGGGGGCGTGGC-6.92
Sox6MA0515.1chr2:738599-738609CCATTGTTTT+6.02
Stat6MA0520.1chr2:739041-739056CATTTCTTGGGAAAT+6.12
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_33276chr2:739763-741094H1
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr2738771738871
chr2739492739565
Enhancer Sequence
AGTCATTAAT TTGTAACCAA TTTATCTGTA TCAATTTAGG AATGTGTTGA AATATCAGAA 60
AAGGAAATCT GCTGTGTTTA AATGCTGTAT GTCTTGGATC AAAGATTTAC AATTTAACTG 120
TACTATATAT TCACACATAT AATTAGAAAT AATGGAAATA GTATAGAATT AATTTATTTC 180
TATCTTATCA TCAACTGAAC CATTGTTTTT AAATGTCAGG TTTTACTAAT AATTTCTATT 240
TTCTTTTGTG CAGTCTGTAA ACATCCTGCA TATTTCAAGA GTAATAGAAA CATCAAGTTT 300
GCTGCCTGGC CTCAGGGCTG GGGCAGGGCA GGTGTTTTTA CAGACGCCTC CTACGTCTGT 360
GGTGAATCTC TCAGGCATTT GCTTGGTTAC TATAAACCTT CGGTGTTTCT AGAGTTCTGA 420
CAAAGTTGAT TCTGACCGTT TTGCTCAGTT TTTTCAGTGA TTCTGTGAAG GGACAGACCT 480
TGGATTTTCC TCTCTGCTAT TTTTGCAGAC ATCAGTGATT CTGTTGATCT TTGGTCATTA 540
CACAGTCCTT ATTTTCCGGA ATACACAGCC TGATCACAGT GTGTTATTCT GATTTAAAAT 600
TTCACTGTAT GGTGATTTGT TAAACTGTTT AGCTATTTTT ACATTTCTTG GGAAATTTTG 660
GAAAATTTCC CCCAAAAAAC AACTTTTTGG GGAAAAATTA AATGATAATT CTTTCTTGTA 720
GTGAACTCCA GGTTTCAGCA TCCATGCTAT TCTCTCCCCA AAACATTAGG CGAGAATCGT 780
TTCCTCTTTT CCTATCCTGG GAAGATGAGA TGTGAGCTGA GCCCTATTTC TTTTACACAC 840
TTAGAACAAT TTTTCATGAA AGCCATTTAG ACCTGGATTT TCTTTACCGC TAGGCTTCTA 900
ATTATGTTTT GCTTATAATT TACATTATTT TAAATTAACA AATCATAATT GTATGATATT 960
TATGGAGCAC AATGCGATGC TATGACGTAT GTTTTCAGTG TAGAAGGATT AACTCAAGCC 1020
AATCACACAC TGCGCCTCAC ATACTTGCTG TTTTGGGGCC ATAGATTTGA AATGTGTCCT 1080
CTTAGTGCCT GTGACATACA CGTGCGTCAT TGCTGTGCAG GAGGCAGGGG AATGGGGGGC 1140
CAGGGAGTGG GGAGCTGGAG TCACAGGACC CAAAGTGACA GGTGCATGGA GGAATGAGCT 1200
TTTTATTTAT TCATTACTTT CATGTCCCCA TGCAGCAGTC ACAGAAAAAA AAAACATGTA 1260
AGTAAGAAAA ATTTTGAATG TAAACTAGAG AGTAGTTAGT GGCCCTATTG TAGACTAAAT 1320
AATGGCCTCC TACAGATACC CATGTTGCAG TCGGCGGAGC CTGTGAATGT CCCTTCCACG 1380
GACCCTGCAG GTGGGCTCAG CGAAGGGCCT GAAGATGGGA GCTGACTGTC CTGGGGGGTC 1440
CACTGGAATC GCAGAGGGCC TCGTCAGAGG GAGGCAGAGA TCGGAGTGAA CCAGCCGCAA 1500
GCCAAGCACT GCGGGCACCA GGAAAGCTGG AGAGGCAGCG AGGATCTTGG GTTAGAGCCT 1560
AGTGAGGGGG CGCGGCCCAG CCAGGAAGGC AGCCAGGATC TTCCCTCAGA GCCTAGCGAG 1620
GGGGCGCGGC CCAGCCAGGA GAGCTGGAGA GGCAGCGAGG ATGTTCCCTC AGAGCCTGGC 1680
GAGGGGGCGT GGCCCAGCCA GGAGGGCGGG AGAGGCAGTG AAGATCTTCC CTCAGAGCCT 1740
GGCGAGGGGG CGCGGCCCAG CCAGGAGAGC TGGAGAGGCC CGGAGGATCT TCCCTCAGAG 1800
CCTAGCGAGG GAGCGCGGCC CAGCCAGGAG AGCTGGAGAG GCAGCCAGGA TCTTCCCTCA 1860
GAGCCTGGCG AGTGAGGGCG GCCCAGCCAG GAGAGCTGGA GAGGCAGCGA GGATGTTCCC 1920
TCAGAGCCTG GCGAGGGGGC GTGGCCCAGC CAGGAGGGCG GGAGAGGCAG TGAAGATCTT 1980
CCCTCAGAGC CTGGGGAGGG GGCGGGGCCC AGCCAGGAGA GCTGGAGAGG CAGCCAGGAT 2040
CTTCCCTCAG AGCCTGGCGA GGGGGCGCGG CCCAGCCAGG AGAGCTGGAG AGGCAGCGAG 2100
GATCTTCCCT CAGAGCCTAT CTAGGGGGCG CGGCCCAGCC AGGAGAGCTG GAGAGGCAGC 2160
GAAGATCTTC CGTTAGAGCC CAGCGAGGGG GTGTGGCCCA GCCAGGAGGG CTGGAGAGGC 2220
AGCGAGGATC TTCCCTAAGA GCGTGGCGAG GGGGCGTGGC CCAGCCAGGA GAGCTGGAGA 2280
GGCAGCGAGG ATCTTCCCTC AGAGCCTGGC GAGGGGGCGC GGCCCAGCCA GGAGAGCTGG 2340
AGAGGCAGCG AAGATCTTCC GTTAGAGCCC AGCGAGGGGG CGTGGCCCAG CCAGGAGGGC 2400
TGGAGTGGCA GCCAGGATCT TCCCTCAGAG CCTGGCGAGG GGGCGGGGCC CAGCCAGGAG 2460
AGCTGGAGAG GCAGCCAGGA TCTTCCCTTA GAGCCCGGCG AGCGGGCGCG GCCCTGCCTA 2520
CACCCCGACT TCATCCCAGT GAGGAGGACG TCGGACTTCT GGCCTCCAGA GCTGTGAGAA 2580
AATACATTTG AGATGTTCAA GCTGCCCAAT GTCTGGTCAT TTGTTACAAA AGATATGGAA 2640
AATCAACGCA CCAGTAACTG GAGAAAATTG ATCACGACTG AAAGGCAGTG GGCAAAACGT 2700
ACTGTTGTAG GTCAGCCCAG ACCAGAAACT GTAAGTCTAT CAAACAGGCG GAGAAAAGCG 2760
GCCACCGTTT TATTCCTCAA GAATTGCACA GTGTTTATTT AAGTCAGCAA CCCTGTGGAG 2820
CAGATTTAAA TTTTATACAA TTTCTAGACA TACGGCATGC ACCCACACGT GTATAATCAT 2880
CATGCATGCA TTATGTATGC ATATGTGTGG AGGGACATAT GCCAGTGTAC GTGTGGGTGG 2940
GTACAATGAG AAAAGATACA GGGTCTTTAA TTATGGAATT ATCCAAGTTT CTATTCTTCT 3000
CAGAAATCAC CATAATGTTT TGGGAATTCT CCCAGACTGC TTCTTGCACT GAAAGTTGTT 3060
CAAAATTCTG TTAGAAATTC TCTATATTTT GTCTAAAAAT ATGCTTCCCA TATTGATGTG 3120
ATACAAGTGA GGAAGAAATT ACAAAATATT CACTGAGTAA AATAGCAATT TAAATGCATT 3180
GAATTAAATT GAGGACCTGA AAACCTAAAC ACAATTTTTC CATTGCTTGG TTTATGTGAA 3240